Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Bosmann

Showing results (1-10 of 84) with videos related to

Pageof 9
Sort By:
American Journal of Respiratory and Critical Care Medicine|May 22, 2020
Complement Activation during Critical Illness: Current Findings and an Outlook in the Era of COVID-19Markus Bosmann
Science Immunology|May 26, 2021
Complement control for COVID-19Markus Bosmann
Clinical and Translational Medicine|February 2, 2013
Therapeutic potential of targeting IL-17 and IL-23 in sepsisMarkus Bosmann, Peter A Ward
Expert Opinion on Therapeutic Targets|March 28, 2014
Protein-based therapies for acute lung injury: targeting neutrophil extracellular trapsMarkus Bosmann, Peter A Ward
Advances in Experimental Medicine and Biology|September 28, 2011
Role of C3, C5 and anaphylatoxin receptors in acute lung injury and in sepsisMarkus Bosmann, Peter A Ward
Trends in Immunology|October 6, 2012
The inflammatory response in sepsisMarkus Bosmann, Peter A Ward
Journal of Leukocyte Biology|August 2, 2013
Modulation of inflammation by interleukin-27Markus Bosmann, Peter A Ward
The American Journal of Pathology|May 31, 2012
A historical perspective on sepsisPeter A Ward, Markus Bosmann
Thrombosis Research|October 20, 2022
Tissue factor in COVID-19-associated coagulopathySaravanan Subramaniam, Hema Kothari, Markus Bosmann
British Journal of Pharmacology|July 8, 2021
Advocacy of targeting protease-activated receptors in severe coronavirus disease 2019Saravanan Subramaniam, Wolfram Ruf, Markus Bosmann
Pageof 9

Showing results (1-10 of 84) with videos related to

Sort By:
Pageof 9
American Journal of Respiratory and Critical Care Medicine|May 22, 2020
Complement Activation during Critical Illness: Current Findings and an Outlook in the Era of COVID-19Markus Bosmann
Science Immunology|May 26, 2021
Complement control for COVID-19Markus Bosmann
Clinical and Translational Medicine|February 2, 2013
Therapeutic potential of targeting IL-17 and IL-23 in sepsisMarkus Bosmann, Peter A Ward
Expert Opinion on Therapeutic Targets|March 28, 2014
Protein-based therapies for acute lung injury: targeting neutrophil extracellular trapsMarkus Bosmann, Peter A Ward
Advances in Experimental Medicine and Biology|September 28, 2011
Role of C3, C5 and anaphylatoxin receptors in acute lung injury and in sepsisMarkus Bosmann, Peter A Ward
Trends in Immunology|October 6, 2012
The inflammatory response in sepsisMarkus Bosmann, Peter A Ward
Journal of Leukocyte Biology|August 2, 2013
Modulation of inflammation by interleukin-27Markus Bosmann, Peter A Ward
The American Journal of Pathology|May 31, 2012
A historical perspective on sepsisPeter A Ward, Markus Bosmann
Thrombosis Research|October 20, 2022
Tissue factor in COVID-19-associated coagulopathySaravanan Subramaniam, Hema Kothari, Markus Bosmann
British Journal of Pharmacology|July 8, 2021
Advocacy of targeting protease-activated receptors in severe coronavirus disease 2019Saravanan Subramaniam, Wolfram Ruf, Markus Bosmann
Pageof 9